Moffitt Cancer Center and Fulgent Pharma Unite to Unveil Nanotherapeutics Cancer Therapies
Moffitt Cancer Center and Fulgent Pharma have formed a partnership to accelerate the development of personalized cancer therapies. •...
eClinical Tech News
Medidata: Enhancing Trials, Transforming Patient Care Worldwide
Medidata, a leading clinical trial solutions provider, has partnered with Worldwide Clinical Trials (Worldwide) to leverage Medidata AI. This...
Flatiron Health, Cancer Centers Align on Data Capture
Flatiron Health, a healthcare technology company, has joined forces with the Association of Cancer Care Centers (ACCC) to improve...
Reflow Medical Completes Enrollment in the DEEPER-Reveal Clinical Trial
Reflow Spur™ Stent Clinical Trial Concludes Enrollment Reflow Medical, Inc. has successfully completed enrollment in the DEEPER REVEAL clinical...
Kite and Arcellx Advance Multiple Myeloma Program with Anti-BCMA CAR-T Momentum
Arcellx and Kite have partnered on the development of anitocabtagene autoleucel (anito-cel), a BCMA CAR T cell therapy for...
Merck’s KEYNOTE-B21 Trial: Failed To Meet Primary Endpoint For Endrometrial Cancer
Merck’s Phase 3 KEYNOTE-B21 trial has shown that its anti-PD-1 therapy, KEYTRUDA, in combination with chemotherapy, did not improve...
SPT-300: A Promising Oral Neurosteroid for Mood and Anxiety Disorders
Clinical trials have demonstrated the significant potential of SPT-300, an oral prodrug of the neurosteroid allopregnanolone. The Glyph™ platform...
NIAID Awards $14M for Institutional Review Services to Advarra
The National Institutes of Health (NIH) has chosen Advarra as its exclusive single institutional review board (sIRB) for clinical...
Medpace First Quarter 2024: Strong Financial Gains
Medpace Holdings reported a significant financial performance for the first quarter of 2024. Revenue soared by 17.7% to $511...